Callan Capital’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$919K Buy
14,929
+4,322
+41% +$236K 0.07% 123
2024
Q4
$531K Buy
10,607
+229
+2% +$13.2K 0.04% 167
2024
Q3
$688K Buy
10,378
+1,585
+18% +$97.8K 0.05% 142
2024
Q2
$511K Buy
8,793
+1,754
+25% +$107K 0.04% 155
2024
Q1
$428K Buy
7,039
+3,344
+91% +$209K 0.04% 157
2023
Q4
$239K Buy
+3,695
New +$218K 0.02% 196

Other funds holding BUD

Callan Capital's BUD Position: Q1 2025 in Review

Callan Capital increased its AB InBev (BUD) stake by 41% in Q1 2025, buying an estimated $236K and bringing the position to 14,929 shares worth $919K. The position accounts for 0.07% of the portfolio, ranked #123.

Callan Capital first reported a position in BUD in Q4 2023 and has held it in 6 quarters since. 495 funds tracked by Wall St. Rank hold BUD as of Q1 2025.

  • Callan Capital held 14,929 shares of AB InBev worth $919K as of Q1 2025.
  • Callan Capital bought 4,322 AB InBev shares in Q1 2025, an estimated $236K.
  • AB InBev made up 0.07% of Callan Capital's portfolio in Q1 2025, its #123 holding.
  • Callan Capital first reported a position in AB InBev in Q4 2023 and has held it in 6 quarters since.
  • 495 funds tracked by Wall St. Rank held AB InBev as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.